ERBB2 and cancer: Moreover, HER2-positive cancers showed that a high WWOX/HIF1A ratio is associated with improved molecular features and clinical outcomes, but multivariate survival modeling found age and stage to be the only significant independent predictors, suggesting the need for larger studies to clarify the standalone effect of the ratio.